Cancer in Fanconi anemia [4]

Blood

Volumn 101, Issue 5, 2003, Pages 2072-2073

  Alter, Blanche P ^a   Greene, Mark H ^b   Velazquez, Isela ^b   Rosenberg, Philip S ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BONE MARROW DEPRESSION; CANCER; CANCER EPIDEMIOLOGY; CANCER RISK; CANCER SUSCEPTIBILITY; DATA ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; FANCONI ANEMIA; HEALTH SURVEY; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LETTER; LEUKEMIA; MAJOR CLINICAL STUDY; MYELODYSPLASTIC SYNDROME; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SELF REPORT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 0037370793     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-11-3597     Document Type: Letter

References (5)

1. Rosenberg PS, Greene MH, Alter BP. Cancer incidence in persons with Fanconi anemia. Blood. 2003;101:822-826.
2. Kutler DI, Singh B, Satagopan J, et al. A 20-year perspective of the International Fanconi Anemia Registry (IFAR). Blood. 2003;101:1249-1256.
3. Alter BP. Cancer in Fanconi's Anemia, 1927-2001. Cancer. 2003;97:425-440.
4. Owen J, ed. Fanconi Anemia: Standards for clinical Care, Fanconi Anemia Research Fund, Inc, 1999.
5. Deeg HJ, Socie G, Schoch G, et al. Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients. Blood. 1996;87:386-392.